IBDEI0S7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13224,2)
 ;;=^5000617
 ;;^UTILITY(U,$J,358.3,13225,0)
 ;;=A59.03^^53^589^96
 ;;^UTILITY(U,$J,358.3,13225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13225,1,3,0)
 ;;=3^Trichomonal Cystitis & Urethritis
 ;;^UTILITY(U,$J,358.3,13225,1,4,0)
 ;;=4^A59.03
 ;;^UTILITY(U,$J,358.3,13225,2)
 ;;=^5000349
 ;;^UTILITY(U,$J,358.3,13226,0)
 ;;=E87.6^^53^589^57
 ;;^UTILITY(U,$J,358.3,13226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13226,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,13226,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,13226,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,13227,0)
 ;;=F52.0^^53^589^56
 ;;^UTILITY(U,$J,358.3,13227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13227,1,3,0)
 ;;=3^Hypoactive Sexual Desire Disorder
 ;;^UTILITY(U,$J,358.3,13227,1,4,0)
 ;;=4^F52.0
 ;;^UTILITY(U,$J,358.3,13227,2)
 ;;=^5003618
 ;;^UTILITY(U,$J,358.3,13228,0)
 ;;=F52.22^^53^589^93
 ;;^UTILITY(U,$J,358.3,13228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13228,1,3,0)
 ;;=3^Sexual Arousal Disorder,Female
 ;;^UTILITY(U,$J,358.3,13228,1,4,0)
 ;;=4^F52.22
 ;;^UTILITY(U,$J,358.3,13228,2)
 ;;=^5003621
 ;;^UTILITY(U,$J,358.3,13229,0)
 ;;=F52.8^^53^589^94
 ;;^UTILITY(U,$J,358.3,13229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13229,1,3,0)
 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
 ;;^UTILITY(U,$J,358.3,13229,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,13229,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,13230,0)
 ;;=F52.21^^53^589^33
 ;;^UTILITY(U,$J,358.3,13230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13230,1,3,0)
 ;;=3^Erectile Disorder,Male (Psychogenic)
 ;;^UTILITY(U,$J,358.3,13230,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,13230,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,13231,0)
 ;;=I12.9^^53^589^55
 ;;^UTILITY(U,$J,358.3,13231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13231,1,3,0)
 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
 ;;^UTILITY(U,$J,358.3,13231,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,13231,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,13232,0)
 ;;=N04.9^^53^589^69
 ;;^UTILITY(U,$J,358.3,13232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13232,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,13232,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,13232,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,13233,0)
 ;;=N02.9^^53^589^50
 ;;^UTILITY(U,$J,358.3,13233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13233,1,3,0)
 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
 ;;^UTILITY(U,$J,358.3,13233,1,4,0)
 ;;=4^N02.9
 ;;^UTILITY(U,$J,358.3,13233,2)
 ;;=^5015520
 ;;^UTILITY(U,$J,358.3,13234,0)
 ;;=N06.9^^53^589^86
 ;;^UTILITY(U,$J,358.3,13234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13234,1,3,0)
 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
 ;;^UTILITY(U,$J,358.3,13234,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,13234,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,13235,0)
 ;;=N05.9^^53^589^66
 ;;^UTILITY(U,$J,358.3,13235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13235,1,3,0)
 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,13235,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,13235,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,13236,0)
 ;;=N07.9^^53^589^68
 ;;^UTILITY(U,$J,358.3,13236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13236,1,3,0)
 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
 ;;^UTILITY(U,$J,358.3,13236,1,4,0)
 ;;=4^N07.9
 ;;^UTILITY(U,$J,358.3,13236,2)
 ;;=^5015568
 ;;^UTILITY(U,$J,358.3,13237,0)
 ;;=N15.9^^53^589^92
 ;;^UTILITY(U,$J,358.3,13237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13237,1,3,0)
 ;;=3^Renal Tubulo-Interstitial Disease,Unspec
